Tesis Labs’ mission is to provide patients with access to quality genetic testing and precision medicine while enabling physicians to create personalized care plans for treating each patient’s unique health risks. Our team of clinicians, scientists, pathologists, engineers and technicians is dedicated to delivering better and faster data-backed diagnoses and treatments to all communities we serve.
Ron King is the CEO and Managing Board Member of Tesis. Mr. King is a seasoned health care executive with more than 25 years’ experience in the healthcare industry. Mr. King brings to Tesis the highest level of professionalism which is reflected in his management expertise as it relates to compliance, process improvement, revenue production and maximization. Mr. King has extensive experience with re-engineering and integration of workflow processes of all clinical divisions in the healthcare continuum including Genetic and infectious disease labs, with the goal to improve performance by creating proprietary processes that result in the creation of unique testing panels while concurrently reducing expenses through strategic sourcing, technology platform integration, RPA and process improvements. Mr. King has directed and managed large operations in the health care industry. He has extensive experience with the oversight of all clinical and administrative divisions in the industry including medical group operations and direct patient clinical divisions. Mr. King has spent many years focusing on multiple healthcare systems, with an emphasis on financial and strategic operational planning and collaboration. Mr. King holds a Master of Health Administration from Seton Hall University. Mr. King previously was a member of the ER/Trauma redesign team at Heywood Memorial in Massachusetts, an Adjunct Professor at Wachusett College, teaching on cardiovascular disease, and the Executive Director of One Care at Newport Hospital. Additionally, Mr. King has been a member of the Compliance Committee of North Country Health System in New Hampshire, the National Board of Respiratory Care and the American Association of Respiratory Care.
Dana Dittus has more than three decades of healthcare laboratory and management experience. Ms. Dittus worked recently as the administrative director for Bayonne Hospital Laboratory. Her areas of expertise include product design, clinical research, and esoteric testing across multiple healthcare settings, including hospital, long-term care, and small and large reference laboratory facilities. Ms. Dittus has participated in various inspection processes and worked with departments of health on Ebola and coronavirus testing protocols. She is deeply familiar with College of American Pathologists (CAP) accreditation standards, Joint Commission accreditation and certification, and various state departments of health regulations. Ms. Dittus holds an undergraduate degree in Allied Health from Widener University and an MBA from Holy Family University.
Along with extensive experience in building and managing commercial teams within healthcare, Jason Correll brings to his role as chief revenue officer at Tesis Labs a passion and commitment for delivering the best customer experience to clients and patients. Correll most recently served as vice president of sales at Prescient Medicine (now SOLVD Health), which offered pharmacogenomics and toxicology services nationally. He has worked for both large companies and startups within the medical device community, including GenMark Diagnostics, Dako North America, Leica Biosystems, and Vision BioSystems. Correll has a proven ability to develop and implement successful marketing, sales, and business development strategies that drive revenue growth and company expansion in the healthcare sector.
As laboratory director for Tesis Labs, Cydney Rios oversees all aspects of the company’s clinical diagnostic testing activities. An expert in next-generation sequencing library construction, RNA-sequencing, and primary airway epithelial culture, Ms. Rios also is laboratory director at Tesis Labs in Lafayette, Colorado. Prior to joining Tesis, she worked for 10 years as a lab manager at National Jewish Health in Denver, where she focused on translational genetics of lung diseases. Ms. Rios has conducted research in renal disease and hypertension at the University of Colorado in Denver and prostate cancer research in the Department of Urology at the University of Florida, where she earned a bachelor’s degree in Interdisciplinary Studies: Biology.
As Tesis Labs’ chief information officer, Kyle Britton provides strategic leadership to the company’s information technology securities, services, and solutions. Britton also is chief information officer for our billing company, where he delivers business IT operational consulting services. Previously Britton served as desktop support field supervisor for the State University of New York (SUNY) Oneonta, overseeing and collaborating with an advanced troubleshooting team and providing ongoing training to customer support specialists. In this role, he improved performance and customer engagement while optimizing operations.
Victor Roiter is the Vice President of Sales for Tesis Labs. He has more than 25 years of experience working in laboratory and pharmacy sales. He’s an accomplished leader, with a proven track record for driving growth and profitability with extensive experience in developing revenue teams and strategic partnerships. He oversees the Company’s initiatives for business development and many collaborative relationships in the medical community. Mr. Roiter previously supervised daily operations of multiple medical sales organizations. Prior to Tesis, Mr. Roiter was the President of Nevins Pharmacy and responsible for business development nationally where his responsibility included designing and delivering multi-distribution channel development and management, market analysis, strategic planning, negotiations, project management, productivity, and efficiency improvements in business development workflow. Mr. Roiter has an extensive understanding of integrating the Genetic laboratory industry with leading-edge technology in healthcare. His career has been committed to innovative partnership relationships involving technology and customized medicine enabling better diagnostic results and more distinct therapy decisions for both physicians and hospitals.